NCT02349009View on ClinicalTrials.gov

Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial

PHASE1/PHASE2CompletedINTERVENTIONAL
Enrollment

17

Participants

Timeline

Start Date

June 30, 2015

Primary Completion Date

July 31, 2016

Study Completion Date

September 30, 2016

Conditions
Systemic Scleroderma
Interventions
DRUG

C-82 Topical Gel, 1%

active

DRUG

C-82 Topical Gel, Placebo

placebo

Trial Locations (3)

Unknown

Chicago

Boston

New York

All Listed Sponsors
lead

Prism Pharma Co., Ltd.

INDUSTRY

NCT02349009 - Trial of Topical C-82 in Systemic Sclerosis - A Phase I/II Biomarker and Safety Trial | Biotech Hunter | Biotech Hunter